Pfizer inks up to $10.5 billion deal with China’s Innovent Biologics

Pfizer Inc. and China’s Innovent Biologics Inc. signed a global agreement worth as much as $10.5 billion to develop cancer drugs.

Raccontata damorningstar.combiopharmadive.comthehindubusinessline.comasia.nikkei.comcnbc.comscmp.combenzinga.compharmaceutical-technology.comstartmag.itendpoints.newsqz.comfiercepharma.com